(Q54325283)
Statements
Dramatic response of vemurafenib-induced cutaneous lesions upon switch to dual BRAF/MEK inhibition in a metastatic melanoma patient. (English)
Olivier Michielin
Solange Peters
Hasna Bouchaab
Stefan Zimmerman
Maya Bucher
Olivier Gaide
Igor Letovanec
Krisztian Homicsko
1 October 2014
24
5
496-500